197 related articles for article (PubMed ID: 15181857)
1. [Clinical and pathological analyses of lipoprotein glomerulopathy].
Hu ZX; Zhang XH; Sha ZH; Yang LC; Huang SM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):442-4. PubMed ID: 15181857
[TBL] [Abstract][Full Text] [Related]
2. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.
Chen HP; Liu ZH; Gong RJ; Tang Z; Zeng CH; Zhu MY; Wang JP; Zhou H; Li LS
Chin Med J (Engl); 2004 Oct; 117(10):1513-7. PubMed ID: 15498375
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE.
Sato H; Suzuki S; Kobayashi H; Ogino S; Inomata A; Arakawa M
Clin Nephrol; 1991 Sep; 36(3):127-33. PubMed ID: 1934668
[TBL] [Abstract][Full Text] [Related]
6. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
[TBL] [Abstract][Full Text] [Related]
7. [A case of lipoprotein glomerulopathy and a literature review of the subject].
Hu H; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):320-4. PubMed ID: 22561509
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein glomerulopathy: a case report].
Han HL; Lin S; Song L; Sun LS; Liang H; Zhao LQ; Zhai DP
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):443-4. PubMed ID: 16251059
[No Abstract] [Full Text] [Related]
9. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J
Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
[TBL] [Abstract][Full Text] [Related]
10. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
Boumendjel R; Papari M; Gonzalez M
Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia.
Saito T; Sato H; Kudo K; Oikawa S; Shibata T; Hara Y; Yoshinaga K; Sakaguchi H
Am J Kidney Dis; 1989 Feb; 13(2):148-53. PubMed ID: 2644825
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.
Avila-Casado Mdel C; Perez-Torres I; Auron A; Soto V; Fortoul TI; Herrera-Acosta J
Kidney Int; 2004 Jul; 66(1):133-43. PubMed ID: 15200420
[TBL] [Abstract][Full Text] [Related]
13. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
Han HL; Lin S; Sun LS; Zhang P; Zhai DP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town.
Pasquariello A; Pasquariello G; Innocenti M; Minnei F; Funel N; Lorusso P; Barsotti G
J Nephrol; 2011; 24(3):381-5. PubMed ID: 21534236
[TBL] [Abstract][Full Text] [Related]
15. Microangiopathic glomerulopathy in children with sickle cell anemia.
Vogler C; Wood E; Lane P; Ellis E; Cole B; Thorpe C
Pediatr Pathol Lab Med; 1996; 16(2):275-84. PubMed ID: 9025833
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of lipoprotein glomerulopathy: observation of 6 cases].
Zou GM; Zhuo L; Tan M; Li WG
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2910-2913. PubMed ID: 30293348
[No Abstract] [Full Text] [Related]
17. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
Saito T; Matsunaga A; Oikawa S
Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
[TBL] [Abstract][Full Text] [Related]
18. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
Oikawa S; Suzuki N; Sakuma E; Saito T; Namai K; Kotake H; Fujii Y; Toyota T
Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
[TBL] [Abstract][Full Text] [Related]
20. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.
Hu Z; Huang S; Wu Y; Liu Y; Liu X; Su D; Tao Y; Fu P; Zhang X; Peng Z; Zhang S; Yang Y
Kidney Int; 2014 Feb; 85(2):416-24. PubMed ID: 24025644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]